Patents by Inventor Juan Francisco Espinosa Parrilla

Juan Francisco Espinosa Parrilla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of pentacyclic triterpenes and hydroxytyrosol and derivatives thereof
    Patent number: 10376529
    Abstract: The present invention is related to a product comprising a pentacyclic triterpene of formula (I) and a hydroxytyrosol or derivatives thereof of formula (II), pharmaceutical compositions thereof and their uses as antioxidants, anti-inflammatories and neuron protectors.
    Type: Grant
    Filed: June 12, 2014
    Date of Patent: August 13, 2019
    Assignee: NATAC BIOTECH, S.L.
    Inventors: José Carlos Quintela Fernández, Esther De La Fuente García, Marco Pugliese, Pilar Mancera Aroca, Javier Bustos Santafé, Juan Francisco Espinosa Parrilla, Noemí Virgili Treserres, Blanca Wappenhans Battestini
  • COMBINATION OF PENTACYCLIC TRITERPENES AND HYDROXYTYROSOL AND DERIVATIVES THEREOF
    Publication number: 20160143930
    Abstract: The present invention is related to a product comprising a pentacyclic triterpene and hydroxytyrosol or derivatives thereof, uses, and pharmaceutical composition thereof.
    Type: Application
    Filed: June 12, 2014
    Publication date: May 26, 2016
    Inventors: José Carlos Quintela Fernandez, Esther De La Fuente Garcia, Marco Pugliese, Pilar Mancera Aroca, Javier Bustos Santafe, Juan Francisco Espinosa Parrilla, Noemí Virgili Treserres, Blanca Wappenhans Battestini
  • Diazoxide For Use In The Treatment Of Amyotrophic Lateral Sclerosis (ALS)
    Publication number: 20130143873
    Abstract: The invention relates to the diazoxide or a pharmaceutically acceptable salt thereof for use as a medicament at low doses to treat amyotrophic lateral sclerosis.
    Type: Application
    Filed: August 16, 2011
    Publication date: June 6, 2013
    Applicant: Neurotec Pharma, S.L.
    Inventors: Marco Pugliese, Juan Francisco Espinosa Parrilla, Noemí Virgili Treserres, Pilar Mancera Aroca, Andrea Pastén Zamorano, Josette-Nicole Mahy Gehenne, Manuel Rodríguez Alluè
  • Diazoxide For Use In The Treatment Or Prevention Of A Central Nervous System (CNS) Autoimmune Demyelinating Disease
    Publication number: 20130039905
    Abstract: The invention relates to the use of diazoxide or a pharmaceutically acceptable salt thereof at low doses to treat a CNS autoimmune demyelinating disease selected from selected from multiple sclerosis (MS), clinically isolated syndrome (CIS), tumefactive (tumor-like) M S, Marburg's acute M S, Balós's concentric sclerosis, acute disseminated encephalomyelitis (ADEM), post-vaccinal encephalitis (PVE), post-infectious encephalomyelitis (PIE) and neuromyelitis optica (NMO).
    Type: Application
    Filed: January 4, 2011
    Publication date: February 14, 2013
    Applicant: Neurotec Pharma, S.L.
    Inventors: Marco Pugliese, Josette-Nicole Mahy Gehenne, Manuel Rodríguez Alluè, Juan Francisco Espinosa Parrilla, Noemí Virgili Treserres, Pilar Mancera Aroca, Andrea Pastén Zamorano